Semi-Annual Consolidated Statement Of Income

PhoenixBio Co.,Ltd. - Filing #7352302

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
1,328,631,000 JPY
1,660,292,000 JPY
Cost of sales
439,687,000 JPY
424,355,000 JPY
Ordinary profit (loss)
32,092,000 JPY
446,530,000 JPY
Gross profit (loss)
888,943,000 JPY
1,235,936,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
858,225,000 JPY
771,112,000 JPY
Extraordinary income
17,714,000 JPY
JPY
Extraordinary losses
JPY
5,000 JPY
Operating profit (loss)
30,718,000 JPY
464,824,000 JPY
Profit (loss) before income taxes
49,807,000 JPY
446,525,000 JPY
Income taxes - current
5,317,000 JPY
52,950,000 JPY
Non-operating income
Interest income
4,176,000 JPY
1,069,000 JPY
Non-operating income
9,587,000 JPY
3,736,000 JPY
Non-operating expenses
Interest expenses
1,525,000 JPY
2,602,000 JPY
Non-operating expenses
8,212,000 JPY
22,030,000 JPY
Income taxes - deferred
30,106,000 JPY
-248,000 JPY
Income taxes
35,424,000 JPY
52,701,000 JPY
Profit (loss)
14,383,000 JPY
393,823,000 JPY
Extraordinary income
Extraordinary losses
Profit (loss) attributable to owners of parent
14,383,000 JPY
393,823,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
10,621,000 JPY
JPY
Foreign currency translation adjustment
13,644,000 JPY
26,837,000 JPY
Other comprehensive income
24,266,000 JPY
26,837,000 JPY
Comprehensive income
38,649,000 JPY
420,661,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
38,649,000 JPY
420,661,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.